Status:
COMPLETED
MRI-based Artificial Intelligence Software (NNS-SOT) for Onset Time Estimation in Lesion With Acute Ischemic Stroke
Lead Sponsor:
Nunaps Inc
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
20+ years
Brief Summary
This study evaluates the efficacy of investigational device named Stroke Onset Time Artificial Intelligence(AI) (Model name:NNS-SOT). Using the investigational device, analyze the image and the onset ...
Detailed Description
This clinical trial software medical device (Model name: NNS-SOT) is developed based on artificial intelligence algorithms. Through clinical validation, it will be easier to determine whether the gol...
Eligibility Criteria
Inclusion
- Brain imaging in patients with acute ischemic stroke aged 20 years and older
- Brain imaging of ischemic stroke manifestation lesion confirmed by medical staff in brain MR image
- Brain imaging taken within 24 hours of ischemic stroke symptoms
- Brain imaging including Magnetic Resonance(MR) images (DWI and FLAIR)
- Patients with clearly recorded onset time of acute ischemic stroke symptoms
Exclusion
- Brain imaging used in NNS-SOT development process
- Brain imaging with noise (Artifact)
- Brain images damaged in data
Key Trial Info
Start Date :
October 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 7 2023
Estimated Enrollment :
474 Patients enrolled
Trial Details
Trial ID
NCT06160726
Start Date
October 24 2023
End Date
November 7 2023
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea